GAIN THERAPEUTIC COMMON STOCK

GAIN THERAPEUTIC COMMON STOCK is a security (CUSIP 36269B105) tracked across SEC portfolio filings. 41 institutional managers reported $15.0M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $766K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 41 managers by value.

ManagerLocationValueShares
MARSHALL WACE, LLPLONDON, X0$3.4M1,769,788
Potomac Capital Management, Inc.NEW YORK, NY$2.0M1,008,600
VANGUARD GROUP INCValley Forge, PA$1.8M569,901
JONES FINANCIAL COMPANIES LLLPDES PERES, MO$1.2M631,615
DME Capital Management, LPNew York, NY$1.1M566,130
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$911K431,267
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$869K447,342
JANE STREET GROUP, LLCNEW YORK, NY$496K216,883
BlackRock, Inc.New York, NY$437K225,046
UBS Group AGZurich, V8$428K220,489
Cresset Asset Management, LLCChicago, IL$310K160,000
STATE STREET CORPBOSTON, MA$306K157,537
MORGAN STANLEYNEW YORK, NY$271K139,652
Stratos Wealth Partners, LTD.BEACHWOOD, OH$255K131,621
NORTHERN TRUST CORPCHICAGO, IL$221K113,997

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$776K0.10%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$-10K-0.03%

More